FOR IMMEDIATE RELEASE - Brussels, Belgium, 5 April 2017

GS1, the international standards organisation, welcomes the adoption today of the final EU Regulations on medical devices and on in-vitro diagnostics. GS1 global standards will be used by manufacturers to implement the new EU system of Unique Device Identification (UDI), which aims to support patient safety and supply chain security.

The UDI system intends to provide a globally harmonised framework for identification of medical devices to enhance quality of care, patient safety and business processes. The EU Medical Device Regulation (MDR) and In-vitro Diagnostic Regulation (IVDR), adopted today, define the requirements for the EU UDI system.

GS1 applauds and welcomes the final adoption of the new EU rules on medical devices by the European Parliament, following the adoption by the Council last month. This vote marks a significant achievement, and is the culmination of over four years of intensive work by the Council, the European Parliament and the European Commission with the active support of the business community, civil society and other stakeholders.  

The GS1 system is an integrated suite of global standards that provides accurate identification and communication of information regarding products, patients, assets, services and locations. GS1 standards, including the Global Trade Item Number® (GTIN®), are already widely used by leading healthcare manufacturers.  The GTIN is accepted across the global healthcare industry as a unique identifier for medical and surgical products at every level of packaging. Since 2013, GS1 has been accredited as an issuing agency for UDI by the U.S. Food and Drug Administration (FDA).

“UDI systems based on GS1 standards will benefit patients, the healthcare system, and the medical device industry. GS1 standards assist healthcare organisations around the world to quickly and efficiently identify medical devices in the case of recall. They improve the accuracy and specificity of adverse event reporting and provide a foundation for a global, secure distribution chain. They also offer a clear way of documenting use of medical devices in electronic health records and clinical information systems”, stated Miguel Lopera, GS1’s CEO.  

Bruno Aceto, GS1 in Europe’s Chairman, said “The EU has made safety and integrity of the global healthcare supply chain a strategic priority by adopting legislation for UDI for medical devices. The successful implementation of UDI by all healthcare stakeholders, from manufacturers to healthcare providers, will depend on several factors, including a globally standardised and harmonised system. The 47 national organisations composing GS1 in Europe, the European platform of GS1, are available to help companies implement the GS1 standards to answer regulatory requirements.”

GS1 has already started work to ensure that healthcare manufacturers from around the world, can create and maintain UDI numbers by following the EU Regulations and the GS1 General Specifications. According to the Regulations, a UDI number must be applied to the medical device label, its packaging and, in some cases, the device itself. Required product data must be submitted to Eudamed, the central European database. GS1’s global identification and coding systems are compliant with relevant international ISO standards.

###

For more information, please visit the GS1 UDI resource web page: http://www.gs1.org/healthcare/udi

 

GS1 contact:

Géraldine Lissalde-Bonnet
GS1 Global Office
Director Public Policy

Email: geraldine.lissalde.bonnet@gs1.org

 

Access the pdf version of the press release here.